The abstract is read at the publisher; the summary is JClub's.
PELSA enables proteome-wide identification of ligand-targeting proteins and binding regions by using dose-dependent, ligand-protected digestion with 0.5 mg ml−1 trypsin.
- Why it matters: Mapping which proteins and regions bind diverse ligands is difficult, and modification-based assays can fail when ligands cannot be derivatized.
- What they did: The protocol adds ligand to cell lysate, digests briefly with 0.5 mg ml−1 trypsin, then uses PELSA-Decipher to process raw data and visualize binding-site signals.
- The result: Applied to staurosporine, 5-methyltetrahydrofolate, and dose-dependent HSP90-family inhibitor binding, the workflow finishes in 2 days and supports quantitative interaction analysis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.